(6R)-2-(4-benzylpiperazin-1-yl)-4-oxo-N-phenyl-5,6-dihydro-1H-pyrimidine-6-carboxamide

ID: ALA4637674

Chembl Id: CHEMBL4637674

PubChem CID: 2008039

Max Phase: Preclinical

Molecular Formula: C22H25N5O2

Molecular Weight: 391.48

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C1C[C@H](C(=O)Nc2ccccc2)NC(N2CCN(Cc3ccccc3)CC2)=N1

Standard InChI:  InChI=1S/C22H25N5O2/c28-20-15-19(21(29)23-18-9-5-2-6-10-18)24-22(25-20)27-13-11-26(12-14-27)16-17-7-3-1-4-8-17/h1-10,19H,11-16H2,(H,23,29)(H,24,25,28)/t19-/m1/s1

Standard InChI Key:  SWTXAJSGUJNKFS-LJQANCHMSA-N

Associated Targets(non-human)

Falcipain 2 (539 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Cysteine protease falcipain-3 (103 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 391.48Molecular Weight (Monoisotopic): 391.2008AlogP: 1.69#Rotatable Bonds: 4
Polar Surface Area: 77.04Molecular Species: NEUTRALHBA: 5HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.23CX Basic pKa: 7.60CX LogP: 1.75CX LogD: 1.28
Aromatic Rings: 2Heavy Atoms: 29QED Weighted: 0.83Np Likeness Score: -1.36

References

1. Rana D, Kalamuddin M, Sundriyal S, Jaiswal V, Sharma G, Das Sarma K, Sijwali PS, Mohmmed A, Malhotra P, Mahindroo N..  (2020)  Identification of antimalarial leads with dual falcipain-2 and falcipain-3 inhibitory activity.,  28  (1): [PMID:31744777] [10.1016/j.bmc.2019.115155]

Source